During the recent episode of ‘America Reports,’ Dr. Mahsa Tehrani, a board-certified rheumatologist, joined the discussion to provide an in-depth analysis of hormone replacement therapy’s role in addressing menopausal symptoms. She emphasized that while HRT carries some risks, especially for long-term use, the benefits can be substantial for women experiencing severe symptoms.
Dr. Tehrani pointed out that HRT can effectively manage hot flashes, night sweats, and vaginal dryness, which are common during menopause. She also highlighted that estrogen therapy can help prevent bone loss, reducing the risk of osteoporosis. However, she stressed the importance of weighing these benefits against potential side effects, such as increased risks of blood clots and breast cancer, particularly in older women.
The FDA’s decision to revisit HRT comes after recent studies have suggested that the treatment might be more beneficial than previously thought for certain patient groups. This reconsideration could influence medical guidelines and patient treatment options, offering a potential shift in how menopausal health is managed in the coming years.